Upcoming Issue Highlights
CapsCanada
SOHO Expo

Prostate Disease Medication and Type 2 Diabetes

| May 31, 2019

Men's Health

A recent study conducted at the University of Edinburgh found that men who take medicine for prostate disease specifically, 5-alpha-reductase inhibitors, have an increased risk of developing type 2 diabetes. The commonly prescribed drug decreases production of the hormone androgen and reduces a prostate-related symptom of reduced urinary flow. Researchers concluded that these men should monitor their health more closely when taking this medication and be on the lookout for warning signs of diabetes but did not advise that the medication should be stopped.
https://www.sciencedaily.com/releases/2019/04/190411101813.htm

For More Information:

Daily Manufacturing, https://dailymfg.com
Nutrigold, https://nutrigold.com
Pure Essence, https://www.pureessencelabs.com
Quantum Nutrition Labs, https://qnlabs.com
Rainbow Light, https://www.rainbowlight.com

Feature

A recent study conducted at the University of Edinburgh found that men who take medicine for prostate disease specifically, 5-alpha-reductase inhibitors, have an increased risk of developing type 2 diabetes. The commonly prescribed drug decreases production of the hormone androgen and reduces a prostate-related symptom of reduced urinary flow. Researchers concluded that these men should monitor their health more closely when taking this medication and be on the lookout for warning signs of diabetes but did not advise that the medication should be stopped.
https://www.sciencedaily.com/releases/2019/04/190411101813.htm

For More Information:

Daily Manufacturing, https://dailymfg.com
Nutrigold, https://nutrigold.com
Pure Essence, https://www.pureessencelabs.com
Quantum Nutrition Labs, https://qnlabs.com
Rainbow Light, https://www.rainbowlight.com

Related Articles